Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.66 USD
Change Today -0.05 / -2.92%
Volume 1.4M
CTIC On Other Exchanges
Symbol
Exchange
BrsaItaliana
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis A. Bianco CPA

Co-Founder, Principal Financial Officer, Principal Accounting Officer, Chief Governance Officer, Executive Vice President of Finance & Administration and Secretary, CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

61$2,178,914
As of Fiscal Year 2014

Background*

Mr. Louis A. Bianco, CPA is a Co- Founder of CTI BioPharma Corp. and has been its Executive Vice President of Finance and Administration since February 1, 1992. Mr. Bianco serves as Principal Accounting Officer, Principal Financial Officer and Secretary of CTI BioPharma Corp. and has been its Chief Governance Officersince September 2013. From January 1989 to January 1992, he served as a Vice President at Deutsche Bank Capital Corporation in charge of risk management. ...

Read Full Background

Corporate Headquarters*

3101 Western Avenue
Seattle, Washington 98121

United States

Phone: 206-282-7100
Fax: 206-284-6206

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
New York University

Other Affiliations*

Annual Compensation*

Salary$360,000
Bonus$234,000
Total Annual Compensation$594,000

Stock Options*

Restricted Stock Awards$1,542,615
All Other Compensation$42,299
Exercisable Options200,428
Exercisable Options Value$118,000
Total Value of Options$118,000
Total Number of Options200,428

Total Compensation*

Total Annual Cash Compensation$636,299
Total Short Term Compensation$594,000
Other Long Term Compensation$1,584,914
Total Calculated Compensation$2,178,914
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTIC:US $1.66 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Ricardo J. Gonzalez Chief Executive Officer, President and Director
Navidea Biopharmaceuticals, Inc
$82.5K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CTI BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.